Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
09/03/2009 | US20090220450 Methods and compositions for wound healing |
09/03/2009 | US20090220444 Antiperspirant and Deodorant Compositions with Improved Protective Action |
09/03/2009 | US20090218731 Shaped body and method for production of said body |
09/03/2009 | US20090217924 Treatment systems and methods |
09/03/2009 | CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
09/03/2009 | CA2716336A1 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders |
09/03/2009 | CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
09/03/2009 | CA2716256A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
09/03/2009 | CA2716250A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
09/03/2009 | CA2714721A1 Anti-allergic agent |
09/03/2009 | CA2713776A1 New macrolides and their use |
09/03/2009 | CA2620242A1 Topical soothing bruise healing preparation |
09/02/2009 | EP2095820A1 Fermented milk for improving and/or treating skin and method for producing the same |
09/02/2009 | EP2094289A1 Conjoint therapy for treating fibrotic diseases |
09/02/2009 | EP2094286A2 Compositions and methods of inducing hair growth utilizing continus coggygria |
09/02/2009 | EP2094277A1 A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them |
09/02/2009 | EP2094271A2 Drug combinations for treating airway diseases |
09/02/2009 | EP1957098B1 Management of non septic patients suffering from partial thickness burns by administration of activated protein c |
09/02/2009 | EP1496890B1 Substituted beta-aminoalcohols used as medicaments |
09/02/2009 | EP1478365B1 Combination consisting of trapidil and 5ht2-serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis |
09/02/2009 | EP1470137B1 Edg receptor agonists |
09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
09/02/2009 | EP1411913A4 Antimicrobial nanoemulsion compositions and methods |
09/02/2009 | EP1392349B1 Use of angiotensinogen and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
09/02/2009 | CN101519439A Freezeproof polypeptide, synthesis, composition containing same and application thereof |
09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
09/02/2009 | CN101518639A Drug for treating acne |
09/02/2009 | CN101518620A Chinese medicinal preparation for treating alopecia areata |
09/02/2009 | CN101518614A Chinese patent medicine for treating chloasma |
09/02/2009 | CN101518608A Anti-candidiasis albrican cream and preparation method thereof |
09/02/2009 | CN101518602A Anti-herpes zoster traditional Chinese medical composition and preparation method thereof |
09/02/2009 | CN101518601A Anti-eczema traditional Chinese medical composition and preparation method thereof |
09/02/2009 | CN101518600A Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof |
09/02/2009 | CN101518596A Pharmaceutical composition for curing thermal damage of mammal or human and preparation method thereof |
09/02/2009 | CN101518580A Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof |
09/02/2009 | CN101518578A Powder for curing dermatophytosis and preparation method thereof |
09/02/2009 | CN101518569A Human sterilizing liquid containing majoram oil and production method thereof |
09/02/2009 | CN101518554A Oral medicinal preparation of hairy holly root total aglycon, preparation method and application thereof |
09/02/2009 | CN101518544A Quickly-effective beriberi powder |
09/02/2009 | CN100534997C C-aryl glucoside SGLT2 inhibitors and method |
09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
09/02/2009 | CN100534981C 2-propylidene-19-nor-vitamin d compounds |
09/02/2009 | CN100534446C Oral skin care composition |
09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
09/01/2009 | US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors |
09/01/2009 | US7582445 Anti-interferon-α antibodies |
09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
09/01/2009 | US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
09/01/2009 | US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof |
09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
09/01/2009 | US7582287 Method for treating cervical cancer |
09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
09/01/2009 | CA2421761C Crab apple fruit polyphenol and production process thereof |
09/01/2009 | CA2210812C T-cell affecting peptides |
08/27/2009 | WO2009105647A1 Methods for the treatment of dermatological disorders |
08/27/2009 | WO2009105294A2 Topical compositions and methods for whitening skin |
08/27/2009 | WO2009103959A2 Medicament |
08/27/2009 | WO2009103816A1 Method for treatment of photosensitivity and phototoxicity |
08/27/2009 | WO2009103754A2 Novel use of 3,3'-diindolylmethane |
08/27/2009 | WO2009103501A1 Means and methods for controlling commensales |
08/27/2009 | WO2009103500A1 Means and methods for controlling commensales |
08/27/2009 | WO2009103427A2 Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation |
08/27/2009 | WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
08/27/2009 | WO2009103123A1 Dendrimeric enzyme inhibitors |
08/27/2009 | WO2009086439A3 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
08/27/2009 | WO2009086438A3 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
08/27/2009 | WO2007143231A3 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
08/27/2009 | US20090215902 Methods for the treatment of dermatological disorders |
08/27/2009 | US20090215887 5-hydroxy-2-methyl-4h-pyran-4-one esters as novel tyrosinase inhibitors |
08/27/2009 | US20090215884 Method for wound healing |
08/27/2009 | US20090215851 Method of Preparing a Porphyrin Derivative, a Porphyrin Derivative, Use of Said Porphyrin derivative and a pharmaceutical composition containing said porphyrin derivative |
08/27/2009 | US20090215849 High stability aqueous gels comprising metronidazole and methods for the preparation thereof |
08/27/2009 | US20090215739 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
08/27/2009 | US20090215707 Compound having cyclic structure and use thereof |
08/27/2009 | US20090215702 Uv-Induced Dermatitis Inhibitor and Atopic Dermatitis Inhibitor |
08/27/2009 | US20090215690 Dickkopf1 (Dkk1) is a dual function protein demonstrates a mechanism for the coordination of cell migration and antagonism of Wnt/ beta -catenin signaling during developmental and pathological processes; finding therapeutic anticarcinogenic agent for breast cancer |
08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
08/27/2009 | US20090215164 Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases |
08/27/2009 | US20090214666 Chitin microparticles and their medical uses |
08/27/2009 | US20090214628 Methods and compositions for treatment of skin |
08/27/2009 | US20090214622 Nanoporous Membrane and Method of Preparation Thereof |
08/27/2009 | US20090214565 Anti-Interferon Alpha Monoclonal Antibodies and Methods For Use |
08/27/2009 | US20090214549 Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field |
08/27/2009 | US20090214512 Methods of treating skin disease, scalp disease, sensitive skin or suppressing hair loss with microbubble washing compositions |
08/27/2009 | US20090214504 Methods and Compositions for Topical Treatment of Medical Conditions Including Wounds and Inflammation |
08/27/2009 | US20090214460 Composition Comprising a Monomer Compound Exhibiting an Optical Property, Method Making Use of Said Composition, a Monomer Compound and a Polymer Containing Said Monomer Compound and the Use Thereof |
08/27/2009 | DE202008005278U1 Hautschutzzusammensetzung Skin-protective composition |
08/27/2009 | CA2753021A1 Medicament |
08/27/2009 | CA2716509A1 Method for treatment of photosensitivity and phototoxicity |
08/27/2009 | CA2716255A1 Cosmetic and dermatological formulations of mntf peptides |
08/27/2009 | CA2713555A1 Topical compositions and methods for whitening skin |